Jacobs Levy Equity Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.32M | Sell |
|
|||||
|
2024
Q1 | $1.89M | Sell |
|
|||||
|
2023
Q4 | $3.16M | Sell |
|
|||||
|
2023
Q3 | $2.22M | Buy |
|
|||||
|
2023
Q2 | $595K | Buy |
|
|||||
|
2023
Q1 | $247K | Buy |
|
|||||
|
2022
Q4 | $910K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $912K | Buy |
|
|||||
|
2020
Q3 | $1.3M | Sell |
|
|||||
|
2020
Q2 | $1.98M | Buy |
|
|||||
|
2020
Q1 | $1.2M | Sell |
|
|||||
|
2019
Q4 | $2.46M | Buy |
|
|||||
|
2019
Q3 | $1.18M | Buy |
|
|||||
|
2019
Q2 | $1.44M | Sell |
|
|||||
|
2019
Q1 | $1.27M | Buy |
|
|||||
|
2018
Q4 | $375K | Buy |
|
|||||
|
2018
Q3 | $348K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $313K | Buy |
|